Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NPIPB14P (Nuclear pore complex interacting protein family member B14, pseudogene) is annotated as a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they usually arise from gene duplication or retrotransposition events. As a pseudogene, NPIPB14P is not known to produce a functional protein product or to serve as an active molecular target for therapeutic intervention. There are no known biological functions, disease associations, interacting drugs, or mechanisms of action for NPIPB14P[5]. This entity is not considered a therapeutic target, receptor, or biologically active molecule. It is not equivalent or directly related to the nuclear pore complex or nucleoporins, which do constitute biologically significant complexes and targets[1][2][3]. The naming suggests historical or sequence similarity to nuclear pore complex proteins, but as a pseudogene, NPIPB14P does not perform these functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex interacting protein family member B14, pseudogene (NPIPB14P).